19198-Leukemia-CLL-502

Leukemia

An Open Label Compassionate Use Trial of Ublituximab and/or Umbralisib (TGR-1202) in Combination with other Novel Agents or as Single Agents in Subjects Currently Receiving Treatment on a TG Therapeutics Study (UTX-TGR-501)

  • Details

ClinicalTrials.gov ID: NCT03207256
Diagnosis Type: CLL
USOR Number:

  • Address

5206 Research Dr
San Antonio, TX 75204
P: (210) 595-5300

Search by practice name, trial titles, indicators and specific disease types.